NEW YORK, March  27, 2026  (GLOBE NEWSWIRE) --   VisionSys AI Inc. (NASDAQ:VSA) (&#34;VisionSys&#34; or the &#34;Company&#34;), an emerging technology services company specializing in brain-machine interaction businesses

VisionSys AI Inc. Announces Pricing of $3 Million Registered Direct Offering

VisionSys AI Inc. Announces $3 Million Direct Offering of ADS

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NEW YORK, March  27, 2026  (GLOBE NEWSWIRE) --   VisionSys AI Inc. (NASDAQ:VSA) (&amp;#34;VisionSys&amp;#34; or the &amp;#34;Company&amp;#34;), an emerging technology services company specializing in brain-machine interaction businesses</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>VisionSys AI Inc. has entered a securities purchase agreement to sell 3 million ADS at $1.00 each, expecting to raise approximately $3 million. The offering, facilitated by Univest Securities, aims to support expansion in AI-driven healthcare solutions, potentially enhancing value for investors post-closure.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>VisionSys AI Inc. announces a direct offering of 3 million ADS.</li><li>Offering set at $1.00 per ADS, totaling $3 million gross proceeds.</li><li>Closing expected on or around March 30, 2026.</li><li>Univest Securities, LLC is the sole placement agent for this offering.</li><li>Funds will support growth in AI-powered healthcare technology.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>VisionSys AI Inc. (VSA)</strong>: Direct offering enhances liquidity, aiding potential growth in AI solutions.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>The event fits &#039;Corporate Developments&#039; as it reflects strategic financial maneuvers that could strengthen VSA&#039;s market position and facilitate future growth, especially in the competitive AI sector.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Direct offering could dilute existing shares but may improve financial stability.</li><li>Institutional investment signals confidence in VisionSys&#039; future prospects.</li><li>Increased cash reserves may finance innovation in AI technology.</li><li>Positive market reception could lead to upward pressure on share price.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>3 million ADS offered at $1.00 each.</li><li>Estimated gross proceeds of $3 million.</li><li>Closing expected by March 30, 2026.</li><li>Univest Securities acting as placement agent.</li><li>Offering registered under shelf registration effective August 21, 2025.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Buy VSA as the offering enhances cash flow potential to support growth.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p>NEW YORK, March  27, 2026  (GLOBE NEWSWIRE) --   VisionSys AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/VSA">VSA</a>) (&#34;VisionSys&#34; or the &#34;Company&#34;), an emerging technology services company specializing in brain-machine interaction businesses leveraging core algorithms and related software and hardware systems, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 3,000,000 American Depositary Shares ("ADS") (or pre-funded warrants in lieu of ADS), at an offering price of $1.00 per ADS.</p>  <p>The gross proceeds to the Company from the registered direct offering are estimated to be approximately $3 million before deducting the placement agent's fees and other estimated offering expenses. The offering is expected to close on or about March 30, 2026, subject to the satisfaction of customary closing conditions.</p>  <p>Univest Securities, LLC is acting as the sole placement agent.</p>  <p>The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-284305) previously filed by the Company with the U.S. Securities and Exchange Commission ("SEC") and became effective by on August 21, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC&#39;s website located at <a href="https://www.globenewswire.com/Tracker?data=lVVqc8y6tr-MZIULaiJviW3QIVuWARiJsxetQFkOpCLKX6GxqvaiZfphaEBvjlgpYrML5CT_t26T8cXW-MIkKQ==" rel="nofollow" target="_blank">http://www.sec.gov</a>. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC at <a href="https://www.globenewswire.com/Tracker?data=yCTJjWxUyHFheCe6rwh-e59Qrl7thXnbcUao9ZTf1TaDB8-TRLsEE8nOET_A8UPaBA1kRc8RfBgwJEqr2UcMrQ==" rel="nofollow" target="_blank">info@univest.us</a>, or by calling +1 (212) 343-8888.</p>  <p>This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC&#39;s website at <a href="https://www.globenewswire.com/Tracker?data=atWQp-x3EkQx-jOtePQrdASPgRUOG90rd3Z8QNbut2q-DkGQiEuGNk11bU5GgGWvKo89vG0SgjDNt-PkON59tw==" rel="nofollow" target="_blank">www.sec.gov</a>.</p>  <p><b>About VisionSys AI Inc.</b></p>  <p>VisionSys AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/VSA">VSA</a>) is an emerging technology services company, specializing in brain-machine interaction businesses leveraging core algorithms and related software and hardware systems. The Company is dedicated to advancing AI-powered healthcare and biotech solutions that transform industries. Its mission is to empower individuals and organizations through intelligent systems, bridging innovation with real-world impact to create a smarter, more connected future.</p>  <p><b>Forward-Looking Statements</b></p>  <p>Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission.</p>  <p><b>Investor Relations Contact:</b><br></br>Matthew Abenante, IRC<br></br>President<br></br>Strategic Investor Relations, LLC<br></br>Tel: 347-947-2093<br></br><b>Email: </b><a href="https://www.globenewswire.com/Tracker?data=ilCP2LOWofCm-6I1hZJF9Z9KJ1NN8BIOf6FRm6zW9duUr_mbdSsgeVcSiF2tzsGMfs5PQkprstM4TLPLFBU7hDn1ui8AO1qdoLCJXwfDWBXP-0dhAEQ_hqrykebWkhc8b55j_7Cm1OC35rZXfWSHCgxSxzP7RlUtEjbt1grcmHIAT2m2RHenmeWn6qVBBTea5-BLS_YNEkldsidHfGgt21vwpNxZNxS7hfuc0BTkhg7pfq_tJThak9QxLbTTDqFSc-lofFet5Hk4Kw1LNk3uj8S5Lc7r_8_s89sEY9el8o8=" rel="nofollow" target="_blank">matthew@strategic-ir.com</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY3OTk2NCM3NTA3ODE3IzUwMDE1NDc0MA=="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/NTNkMzQ5ZmQtMWU0MC00MTlhLWJjNDAtMTM1YWIwOTNiNWFiLTUwMDE1NDc0MC0yMDI2LTAzLTI3LWVu/tiny/VisionSys-AI-Inc.png" referrerpolicy="no-referrer-when-downgrade"></img>

VisionSys AI Inc. has entered a securities purchase agreement to sell 3 million ADS at $1.00 each, expecting to raise approximately $3 million. The offering, facilitated by Univest Securities, aims to support expansion in AI-driven healthcare solutions, potentially enhancing value for investors post-closure.

VisionSys AI Inc. Announces Pricing of $3 Million Registered Direct Offering

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News